[The role of SASP in tumor microenvironment.]

Naoko Ohtani1

  • 1Department of Pathophysiology, Osaka City University Graduate School of Medicine, Japan.

Clinical Calcium
|May 25, 2017
PubMed

Insights

Cellular senescence, a DNA damage response, normally suppresses tumors. However, senescent cells secrete factors (senescence-associated secretory phenotype) that can aid tissue repair or promote cancer, depending on context.

Area of Science:

  • Cellular Biology
  • Oncology
  • Molecular Biology

Background:

  • Cellular senescence is a key tumor suppression mechanism triggered by DNA damage.
  • Senescent cells, unlike apoptotic cells, survive long-term.
  • This survival allows for the secretion of various factors, creating the senescence-associated secretory phenotype (SASP).

Purpose of the Study:

  • To investigate the dual role of cellular senescence.
  • To understand the implications of the senescence-associated secretory phenotype (SASP).
  • To explore how SASP influences biological outcomes in different contexts.

Main Methods:

  • Analysis of cellular senescence markers.
  • Investigation of secreted factors from senescent cells.
  • Context-dependent evaluation of SASP effects.

Main Results:

  • Senescent cells exhibit a senescence-associated secretory phenotype (SASP).
  • SASP involves the secretion of inflammatory cytokines, chemokines, growth factors, and matrix-remodeling factors.
  • The biological impact of SASP is context-dependent, potentially leading to beneficial tissue repair or detrimental cancer progression.

Conclusions:

  • Cellular senescence has a complex role beyond tumor suppression.
  • The senescence-associated secretory phenotype (SASP) is a critical factor in determining the outcome of senescence.
  • Understanding SASP's context-dependent effects is crucial for therapeutic strategies.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K